Masimo Corporation — Company profile
Healthcare · Medical Devices · United States
Last price 179.95 USD (At close: Jun 9, 2026) · Market cap 9.42B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California. As of June 10, 2026, Masimo Corporation operates as a subsidiary of Danaher Corporation.
Details
| Name | Masimo Corporation |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 2200 |
| Founded | 1989 |
| Ipo Date | 2007-08-08 |
| Ceo | Catherine Szyman |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| Isin | US5747951003 |
| Cusip | 574795100 |
| Cik | 0000937556 |
| Sic | 3845 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Catherine M. Szyman | Chief Executive Officer and Director |
| Micah Young CPA | Executive Vice President and Chief Financial Officer |
| Anand Sampath | Executive Vice President of Operations |
| Charles Dadswell | Executive Vice President and General Counsel |
| Greg Meehan | Chief Commercial Officer |
| Paul Hataishi | Senior Vice President and Chief Accounting Officer |
| Yongsam Lee | Executive Vice President and Chief Information Officer |
| Dr. Steven J. Barker | Chairman of Scientific Advisory Board and Chief Science Officer |
| Matthew Brinckman | Senior Vice President of FP&A and Investor Relations |
| Tim A. Benner | Chief Marketing and Strategy Officer |
Contact
| Address | 52 Discovery, Irvine, California 92618, United States |
| Phone | 949 297 7000 |
| Website | https://www.masimo.com |